Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
240.50    5.00 (2.12%)
Bid:
239.00
Ask:
240.00
Spread: 1.00 (0.418%)
Market Cap: £1.43b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Board Changes

28 May 2021 10:15

RNS Number : 1920A
Mitchells & Butlers PLC
28 May 2021
 

28 May 2021

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

 

Board Changes

 

 

Mitchells & Butlers plc announces the following changes to its Board.

 

Ron Robson, who joined the Board in 2010, and is a nominated representative of the Group's largest shareholder, the Odyzean Group, Imelda Walsh, Chair of the Remuneration Committee, and Colin Rutherford, Chair of the Audit Committee, who both joined the Board in 2013, will all retire from the Board at the end of July 2021.

 

Following these changes , the Board of M&B will be comprised of the non-executive chairman, Bob Ivell, two executive directors (Phil Urban, CEO and Tim Jones, CFO), three independent non-executive directors (Susan Murray, who will remain as senior independent director, Jane Moriarty, who will assume the role of chair of the Audit Committee, and Dave Coplin, who will continue in his role as non-executive director nominated for representation of the "workforce voice") and three non-executive directors representing the interests of the Odyzean Group (Eddie Irwin, Josh Levy and Keith Browne).

 

An announcement in relation to the chairmanship of the Remuneration Committee is expected to be made in the next few months.

 

The office of Deputy Chairman currently held by Mr Robson will not be continued.

 

Commenting on these changes, chairman Bob Ivell said:

 

Ron, Imelda and Colin have provided excellent service to M&B throughout their time on the Board, helping to achieve a significant period of stability for the Company whilst assisting our governance and oversight arrangements.

 

We are extremely grateful to all three of these highly regarded non-executive directors for the support, guidance and enthusiasm which they have brought to the Board and everyone at M&B wishes them every success for the future.

 

In its prospectus issued on 22 February 2021, the Company confirmed that the Odyzean Group, which comprises shareholders with a majority of the shares in the Company, would review the composition of the Board to streamline its decision making and reduce the number of non-executive directors. By making these changes now, the smaller, more agile Board is in line with the Company's stated intentions at the time of the equity raise and it can now focus on supporting and challenging management over the coming months, as the business first recovers and then moves forward again.

 

We hope to make a further announcement in the near future in relation to the position of chair of the Remuneration Committee which should conclude this process.

 

For further information, please contact:

 

Greg McMahon

Company Secretary & General Counsel

0121 498 6514

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKFBPFBKKAPB
Date   Source Headline
27th Jun 202512:00 pmRNSDirector/PDMR Shareholding
23rd Jun 202511:09 amRNSDirector/PDMR Shareholding
30th May 202510:53 amRNSTotal Voting Rights
27th May 202510:40 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSHalf Year Results
15th May 202512:39 pmRNSNotice of Half Year Results
30th Apr 20251:39 pmRNSTotal Voting Rights
28th Apr 202511:43 amRNSDirector/PDMR Shareholding
1st Apr 202511:40 amRNSBlock listing Interim Review
31st Mar 202511:18 amRNSDirector/PDMR Shareholding
31st Mar 202510:24 amRNSTotal Voting Rights
3rd Mar 20251:18 pmRNSDirector/PDMR Shareholding
28th Feb 20258:50 amRNSTotal Voting Rights
3rd Feb 20251:58 pmRNSDirector/PDMR Shareholding
31st Jan 202511:40 amRNSTotal Voting Rights
23rd Jan 20252:52 pmRNSResult of Annual General Meeting
16th Jan 20259:33 amRNSDirector/PDMR Shareholding
15th Jan 20257:00 amRNSFirst Quarter Trading Update
13th Jan 20252:43 pmRNSNotice of First Quarter Trading Update
6th Jan 20252:30 pmRNSDirector/PDMR Shareholding
2nd Jan 20259:56 amRNSTotal Voting Rights
19th Dec 202412:00 pmRNSAnnual Report 2024
10th Dec 20247:59 amRNSDirector/PDMR Shareholding
9th Dec 202410:51 amRNSDirector/PDMR Shareholding
4th Dec 202411:23 amRNSDirector/PDMR Shareholding
4th Dec 20249:30 amRNSDirector/PDMR Shareholding
3rd Dec 202410:57 amRNSDirector/PDMR Shareholding
2nd Dec 202412:12 pmRNSDirector/PDMR Shareholding
29th Nov 20242:28 pmRNSDirector/PDMR Shareholding
29th Nov 202412:12 pmRNSTotal Voting Rights
27th Nov 20247:00 amRNSFull Year Results
25th Nov 202411:23 amRNSNotice of Final Results
11th Nov 20242:30 pmRNSDirector/PDMR Shareholding
31st Oct 20241:00 pmRNSTotal Voting Rights
25th Oct 20243:39 pmRNSHolding(s) in Company
14th Oct 20242:30 pmRNSDirector/PDMR Shareholding
1st Oct 20243:30 pmRNSBlock listing Interim Review
1st Oct 202412:00 pmRNSTotal Voting Rights
26th Sep 20247:00 amRNSPre-Close Trading Update
23rd Sep 20243:00 pmRNSNotice of Fourth Quarter Trading Statement
16th Sep 20242:30 pmRNSDirector/PDMR Shareholding
16th Sep 202411:00 amRNSHolding(s) in Company
30th Aug 202411:45 amRNSTotal Voting Rights
19th Aug 20243:30 pmRNSDirector/PDMR Shareholding
31st Jul 20244:34 pmRNSTotal Voting Rights
25th Jul 20247:00 amRNSThird Quarter Trading Update
22nd Jul 20243:00 pmRNSDirector/PDMR Shareholding
22nd Jul 202411:02 amRNSListing Application
19th Jul 20242:42 pmRNSNotice of Third Quarter Trading Update
3rd Jul 20243:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.